They say, “good talent is hard to find!” This is especially true for emerging high-growth markets where many in the workforce lack the advanced skills necessary to aid their bioproduction needs and expand their market profile. Leveraging the success of the M Lab™ Collaboration Centers, the MilliporeSigma team was able to foster key collaborations with government agencies to provide essential hands-on training programs in various Asia-Pacific countries such as Singapore and Taiwan. In this podcast, we will hear from the individuals that were integral to launching these vital initiatives.
This is part two in the five-part podcast series tackling diverse issues such as the need for speed to market in gene therapy, next-generation bioprocessing, and viral safety assurance in upstream and downstream. Make sure you check back regularly to hear the latest GENcast session.
Panelists:
Chii-Wann Lin, PhD Vice President and General Director of Biomedical Technology and Device Research Laboratories
Industrial Technology Research Institute (ITRI)
Chin Bin Tan
Head of Technology Management, APAC
MilliporeSigma
G Somasundaram
Head of Technology Management, Singapore, Southeast Asia, and Oceania
MilliporeSigma
Maggie Lu, PhD
Former Deputy Division Director of Biomedical Technology and Device Research Laboratories
Industrial Technology Research Institute (ITRI)
